Biomedical subjects

T M Hering

Publications and source records attributed to T M Hering.

7 recordsLinked to original sources

PubMed1991

Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procore protein.

We have studied the biosynthesis of cartilage dermatan sulfate proteoglycan II (DS-PGII) (decorin) using in vitro translation of mRNA to determine the size of the primary gene product and by radiolabeling the protein in the presence of tunicamycin to inhibit the addition of Asn-linked oligosaccharides. Pulse-chase experiments were performed to examine post-translational processing and secretion. Inhibitors of oligosaccharide processing were used to determine whether DS-PGII molecules containing partially processed oligosaccharides could become proteoglycans and be secreted. Cell-free translation of sucrose gradient-fractionated RNA and subsequent immunoprecipitation of the core protein confirmed that the functional translated mRNA is in the size range of the two mRNA species observed by hybridization of chondrocyte RNA with a bone PGII cloned probe and that the translation product is a single protein with an apparent molecular mass of 42 kDa. Digestion of the intact proteoglycan (average molecular mass = 103 kDa) with chondroitinase ABC or AC results in an approximately 48-49-kDa product. Chondrocytes treated with tunicamycin to inhibit Asn-linked oligosaccharide addition synthesize and secrete a glycosaminoglycan (GAG)-substituted proteoglycan (average molecular mass = 86 kDa), yielding a 42-kDa core protein after chondroitinase ABC digestion, showing that Asn-linked oligosaccharides are not required for the addition of GAG chains or secretion. Following a short pulse (10 min) of [3H]leucine, three glycosylated forms of the DS-PGII core protein were observed, one of which is likely to be the precursor form of PGII predicted by the implied protein sequence of both bovine and human cDNA clones. Following the apparent cleavage of the propeptide, GAG-substituted intracellular core protein is detectable. Susceptibility to endoglycosidase H indicates that approximately one-third of the secreted core protein contains exclusively complex-type Asn-linked oligosaccharides and approximately two-thirds contain high mannose as well as complex-type oligosaccharides. Secreted DS-PGII appears to be fully substituted with three Asn-linked oligosaccharide chains. Inhibitors of oligosaccharide processing, however, permitted secretion of GAG-substituted DS-PGII that was fully (three chains) or incompletely (one or two chains) substituted with partially processed Asn-linked carbohydrate chains. By comparison of chondrocyte DS-PGII with fibroblast DS-PGII, we conclude that the addition and processing of Asn-linked carbohydrate chains are directed by the amino acid sequence of the core protein. The results reported here also suggest that the addition of xylose, the initial step in GAG chain synthesis, occurs early in biosynthesis and is determined by the primary amino acid sequence of the core protein.(ABSTRACT TRUNCATED AT 400 WORDS)

Aggrecans↗

PubMed1991

Enhanced sulfated-proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant transforming growth factor-beta 1.

Rabbit articular chondrocytes were incubated with recombinant transforming-growth-factor-beta 1 (rhTGF-beta 1) and its effect on newly synthesized proteoglycan measured. rhTGF-beta 1 stimulated proteoglycan synthesis at a concentration as low as 5 ng/ml without further increases in radiosulfate incorporation up to 50 ng/ml. The quantitative increase in radiosulfate incorporation in rh-TGF-beta 1-treated chondrocytes was greater in the cell-associated culture compartment than in the medium compartment. rhTGF-beta 1 promoted an increased proteoglycan retention in the cell-associated compartment as evidenced by an increase in the t1/2 of retention from 8 h to 11 h. Specific enhanced synthesis of [35S]-methionine-labeled core proteins was seen in rh-TGF-beta 1-treated chondrocytes. rh-TGF-beta 1 increased the synthesis of the 2 core proteins derived from hydrodynamically large proteoglycans. They possessed apparent molecular weights of greater than 480 kD and 390 kD after 3-5% acrylamide gel electrophoresis. A compartmental analysis revealed that the cell-associated culture compartment contained only the larger of the 2 core proteins derived from large proteoglycans. Two other core proteins with apparent molecular weights 52 kD and 46 kD were also stimulated by rhTGF-beta 1. These results indicated that TGF-beta probably plays a significant role in stimulating proteoglycan core protein synthesis in articular chondrocytes and therefore may be an important growth factor in the restoration of cartilage extracellular matrix after injury.

Aggrecans↗

PubMed1990

Biosynthesis and processing of bovine cartilage link proteins.

We have examined posttranslational modifications which are responsible for converting an apparently single precursor (Hering, T. M., and Sandell, L. J. (1988) J. Biol. Chem. 263, 1030-1036) to the two major forms of link protein in bovine articular cartilage. Resistance to endoglycosidases H and F suggests that Asn-linked oligosaccharides of link protein secreted by bovine chondrocytes in culture are of the complex or hybrid type. There is no evidence for O-linked oligosaccharides. There is no apparent precursor-product relationship between link protein (LP)1 and LP2, since after a short pulse with [3H]leucine two forms are present, consistent with the existence of two glycosylation sites. An immunoprecipitate of LP1 from pulse-labeled chondrocytes was observed to show a decrease in electrophoretic mobility and increased microheterogeneity during transit through the Golgi, whereas LP2 did not change. During processing both LP1 and LP2 become endoglycosidase H resistant. LP1, but not LP2, can be biosynthetically labeled with [35S]sulfate. Incorporation of [35S]sulfate is inhibited by tunicamycin, indicating that the sulfate is associated with Asn-linked carbohydrate. Sulfation may be important for normal processing, secretion, or degradation of link protein and with sialylation may confer considerable charge heterogeneity upon LP1. We conclude that there are considerable biochemical differences between glycoproteins LP1 and LP2 which may provide a basis for functional differences.

1-Deoxynojirimycin↗

PubMed1988

Biosynthesis and cell-free translation of Swarm rat chondrosarcoma and bovine cartilage link proteins.

In cartilage, link protein(s) (LP) stabilize proteoglycan aggregates via their specific association with hyaluronic acid and proteoglycan monomers. Two major link glycoproteins are produced in bovine articular cartilage, designated LP1 (49.5 kDa) and LP2 (44.0 kDa), whereas rat chondrosarcoma produces a single link protein species similar in size to bovine LP2. Although multiple link proteins differ to a significant degree in carbohydrate content, it is not known whether they arise from variable glycosylation of a single common protein core or from complete glycosylation of different protein cores. Biosynthesis of these molecules has been studied under conditions where differences generated by N-linked glycosylation would not be evident. Link proteins were immunoprecipitated 1) from cell-free translation products of total cellular and size fractionated RNA and 2) from cell lysates and medium of cultured chondrocytes using short term radioactive labeling of the protein in the presence and absence of tunicamycin. A 42-kDa link protein precursor is synthesized by cell-free translation of either rat chondrosarcoma or bovine chondrocyte mRNa. An apparently single 41.5-kDa link protein is synthesized with inhibition of N-linked glycosylation by tunicamycin, whereas LP1 and LP2 are the mature products of cultured bovine chondrocytes. The size range of translatable rat chondrosarcoma LP mRNA is 4.0-5.5 kilobase pairs and bovine LP mRNA is 3.0-4.5 kilobase pairs, both much larger than required to encode the link protein molecule. These results suggest that a single link protein precursor gives rise to multiple fully glycosylated forms and that link protein is not synthesized as a significantly larger "pro" form.

Animals↗

PubMed1987

Nosocomial graft fragmentation and healing response of an ePTFE angioaccess graft.

This investigation was directed toward the tissue reaction and wound healing response of an ePTFE prosthesis implanted in a human subject as an arteriovenous fistulae for over 7 years. Due to the frequent puncture of the prosthesis for hemodialysis access, the pattern of healing is markedly different from that normally observed in ePTFE grafts in humans. The ePTFE graft material of the AV fistula was completely incorporated in fibrous tissue with prominent pseudointima formation (inner capsule), fibrous tissue within the graft and a well-adhered periadventitial layer (outer capsule). In the portion of the graft most frequently punctured, the wall of the graft was composed mainly of fibrous tissue containing dissociated fragments of ePTFE. Biochemical analysis of the fibrous tissue across the wall of the graft revealed that it contained types I, III, and V collagen, with type I greater than III greater than V. The type V collagen was present in largest percentage at the luminal surface and in decreasing percentage in the ePTFE material and outer capsule. This analysis suggests that collagen type deposition in this prosthesis occurs in a manner similar to a normal healing wound, except for the unusual pattern of type V collagen deposition, which may be an adaptive variation of the healing response.

Adult↗

PubMed1986

Collagen type distribution in healing of synthetic arterial prostheses.

Layers of tissue encapsulating vascular prostheses recovered from humans were extracted and analyzed by SDS-polyacrylamide gel electrophoresis to determine the distribution of genetically distinct collagen types. Type V collagen was in maximal concentration in extracts of tissues nearest to the prosthesis lumen, type III in extracts of chronically inflamed tissue filling the interstices of the porous prosthesis, and type I in extracts of fibrous occlusive or outer capsule tissue. This pattern of distribution of collagen types across the prosthesis wall may have arisen due to the influence of modulating factors originating in the blood flowing through the prosthesis, and factors produced by inflammatory cells chronically present at the tissue-biomaterial interface. The increased proportion of type V collagen at or near the lumen may contribute to the recognized antithrombogenic properties of human pseudointima.

Arteries↗

PubMed1983

Type V collagen during granulation tissue development.

The collagen content, as determined by hydroxyproline assay, of experimental granulation tissue in rats was observed to increase rapidly 21 days, and less rapidly to 90 days of tissue development. Resistance of the collagen to pepsin digestion reached a maximum at 21 days, suggesting more extensive or more stable crosslinking at that time. Type V collagen and the expected collagen types I and III were present in pepsin extracts of the granulation tissue as determined by SDS-polyacrylamide gel electrophoresis. Over 3 months of tissue development the relative quantity of type V collagen, as evidenced by changes in the alpha B chain, varied in parallel with the changing vascularity of the tissue, suggesting an association with capillary endothelial cells and angiogenesis.

Animals↗